T Gammie, A Seyfoddin, SS Hasan, LE Curley - Research in Social and …, 2019 - Elsevier
Background Countries with similar health systems but different medicines policies might result in substantial medicines usage differences and resultant outcomes. The literature is …
A Francis, M Didsbury, WH Lim, S Kim, S White… - Pediatric …, 2016 - Springer
Background Low socioeconomic status (SES) and geographic disparity have been associated with worse outcomes and poorer access to pre-emptive transplantation in the …
Objective and background: The 10-item Birth Satisfaction Scale-Revised (BSS-R) has recently been endorsed by international expert consensus for global use as the birth …
Abstract New Zealand's Pharmaceutical Management Agency (PHARMAC) has been highly successful in facilitating affordable access to medicines through a combination of aggressive …
Background: The Cancer Drugs Fund (CDF) provides£ 200 million annually in England for 'anti-cancer'drugs. Methods: We used a controlled pre-/post-intervention design to compare …
PM Neuwelt, D Gleeson, B Mannering - Critical Public Health, 2016 - Taylor & Francis
The Trans-Pacific Partnership Agreement (TPPA) is a regional trade agreement being negotiated by 12 countries, including New Zealand and the United States of America (USA) …
Objectives To identify priority medicines policy issues for New Zealand. Setting Stakeholders from a broad range of healthcare and policy institutions including primary, secondary and …
R Gauld, J Flett, S McComb, A Gray - Government Information Quarterly, 2016 - Elsevier
This article reports on findings from a longitudinal study of e-government responsiveness. Of course, a key expectation is that e-government will improve responsiveness. The article …